Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astaxanthin for Pain and Inflammation in Advanced Knee Osteoarthritis
NCT05138549Phase 3Terminated
- Sponsor
- Prisma Health
- Start
- Sep 2022
- Primary completion
- Nov 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of astaxanthin in osteoarthritis (OA), sponsored by Prisma Health. Started Sep 2022; status: terminated.
02
Drugs
astaxanthin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05138549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05138549.